Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Lianchun Xiao"'
Autor:
Kian H. Lim, Jeffrey S. Morris, Sadakatsu Ikeda, Hesham M. Amin, Kenna R. Mills-Shaw, Funda Meric-Bernstam, Ahmed Kaseb, Robin Kate Kelley, Benjamin R. Tan, Bhawana George, Lianchun Xiao, Marc Uemura, Andrea Grace Bocobo, Richard B. Lanman, Razelle Kurzrock, Manal M. Hassan, James C. Yao, Robert A. Wolff, Reham Abdel-Wahab, Wei Qiao, Shiraj Sen, Abedul Haque, Asif Rashid, Nora S. Sanchez, Kanwal Pratap Singh Raghav, Kimberly C. Banks, Roberto Carmagnani Pestana, Amir Ali Talasaz
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 25, iss 20
Clin Cancer Res
Clin Cancer Res
Purpose: Molecular profiling has been used to select patients for targeted therapy and determine prognosis. Noninvasive strategies are critical to hepatocellular carcinoma (HCC) given the challenge of obtaining liver tissue biopsies. Experimental Des
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea41216438d763f99cc814dcd6c4ae02
https://escholarship.org/uc/item/51m038zw
https://escholarship.org/uc/item/51m038zw
Autor:
Nathan Fowler, Wing C. Chan, Mariela Sivina, Xuelin Huang, Fredrick B. Hagemeister, Kai Fu, Koichi Takahashi, Richard E. Davis, Michael J. Keating, Julie M. Vose, Susan O'Brien, Yasuhiro Oki, Jorge E. Romaguera, Michelle A. Fanale, Felipe Samaniego, Larry W. Kwak, Julia Hoellenriegel, William G. Wierda, Luis Fayad, Sattva S. Neelapu, Lianchun Xiao, Hagop M. Kantarjian, Jan A. Burger
Publikováno v:
British journal of haematology, vol 171, iss 5
B cell receptor (BCR) signalling is an important pathway in diffuse large B cell lymphoma (DLBCL). In response to BCR triggering, normal and malignant B cells secrete the chemokines CCL3 and CCL4 to attract accessory cells to the tissue microenvironm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e22478e08bfc1f66e36c29ca2a5aff01
https://escholarship.org/uc/item/2gk5x6x7
https://escholarship.org/uc/item/2gk5x6x7
Autor:
Jitesh D. Kawedia, Mary Ann Richie, Zhihong Zeng, Jordan Basnett, Marina Konopleva, Farhad Ravandi, Linda J. Bendall, Elias Jabbour, Michael Rytting, Yanis Boumber, Deborah A. Thomas, Naval Daver, Kirk S. Culotta, Wenbin Liu, Susan O'Brien, Rebecca Garris, Hagop M. Kantarjian, Jorge E. Cortes, Keith A. Baggerly, Hongbo Lu, Lianchun Xiao, Jan A. Burger
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 21, iss 12
Purpose: Previous studies suggest a potential therapeutic role for mTOR inhibition in lymphoid malignancies. This single-center phase I/II study was designed to test the safety and efficacy of the mTOR inhibitor everolimus in combination with HyperCV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6729a83b75b02b7f5388a9cb147d6c5e
https://escholarship.org/uc/item/7pp3g24n
https://escholarship.org/uc/item/7pp3g24n